You are here

Congress Planner

  • Dec 2017
    2

    Baptist Health South Florida

    faculty will engage participants through complex cases, novel treatment strategies and lively panel discussions.This symposium will focus on recent advances in caring for neuro-oncology patients, as well as stroke management, neuro-critical care and neuro-imaging. The expert

    Target Audience:

    Adult and Pediatric Neurologists, Adult and Pediatric Medical Oncologists, Neurosurgeons, Neuro-Oncologists, Medical Oncologists, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Radiation Oncologists, Critical Care Physicians, Neuro Critical Care Physicians, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Neuropsychologists, Critical Care Nurses, Neuroscience Nurses, Neurosurgery Nurses, Nurse Practitioners, Physical Therapists, Respiratory Therapists, Dietitians, Radiology Technologists, Clinical Pharmacists, Rehabilitation and Pain Management Specialists, as well as other specialists interested in the fields of neuro-oncology and neuroscience.

     

    Coral Gables, United States
  • Dec 2017
    5
    Dec 2017
    6

    RSM Professionals and Nutrition Society

    Cancer is no longer a terminal diagnosis. Increasing numbers of people are surviving but with ever more chronic conditions they need sound nutritional advice. However, the scientific evidence to support this is sparse. This conference will explore the role of nutrition at multiple points in the cancer pathway. 

     

    Objectives

    Whilst the evidence base for cancer prevention is growing and consolidating there is a growing need to:

     

    Understand the role of nutrition in chemotherapy (as well as the impact of therapy on nutrition and appetite)

    Provide effective strategies for nutritional support of end-stage care

    Understand the potentially distinct dietary strategies for prevention of cancer recurrence

    Develop the management of the co-morbidities associated with cancer survivorship

     

    The meeting will address the new challenges stemming from the improved prognoses following treatment for cancer. It will cover the mechanistic, human and public health implications, and is poised to draw together international expertise at a timely point in the evolution of development of cancer management and survivorship strategies.

     

    Scientific programme organisers

    Dr Ailsa Welch (University of East Anglia) and Dr Bernard Corfe (University of Sheffield)

     

    Price

    Earlybird rates:

    RSM members: £140 - £295

    NS members: £140 - £250

    Non members: £165 - £385

     

    Standard rates:

    RSM members: £175 - £385

    NS members: £175 - £325

    Non members: £195 - £435

     

    All tickets include a place for a complimentary drinks reception and dinner on Tuesday 5 December 2017.

    London, United Kingdom
  • Dec 2017
    7
    Dec 2017
    8

    NetZealous DBA as GlobalCompliancePanel

    Course "Data Integrity, 21 CFR 11 & Annex 11 Implementation" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

     Overview:

     The Problem:

    We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following:

    • Evolution of 21 CFR Part 11 and Annex 11 and Why they are Back in the News
    • Overview and Key Requirements of Part 11 & Annex 11
    • How to use a Risk Based Assessment to reduce work while still achieving Data Integrity and Compliance?
    • How FDA & other Regulatory Authorities Inspect Computerized Systems for Data Integrity?

    I often refer to 21 CFR 11 and Annex 11 as Good Software Engineering with the Documentation on Steroids! However, unless one knows how to implement Data Integrity, it is often very hard to apply requirements for DATA INTEGRITY to computerized system, and very hard to determine what needs to be done, to meet domestic and / or international regulations or business continuity requirements. In addition, the agencies have stepped up data integrity inspections and the number of citations on the subject are skyrocketing!

    This course is appropriate for beginner and experienced person alike. The topics will build on each other and will give you the latest trends in our heavily regulated industry and how to make it easy for yourself while still achieving data integrity.

    This is a very hands-on class and the attendees will be given take away templates that will enable them to build a complete package to meet Data Integrity Requirements for Computerized Systems

     

    The Seminar:

     

    This hands-on course will provide the attendees with more detailed experience on validation / 21 CFR 11 compliance of a computer system, as well as details for activities associated with computer systems validation as follows:

    1. What is Data Integrity and how is it implemented
    2. How to use Risk Based Assessments to reduce work while still achieving Data Integrity and Compliance?
    3. Data Integrity Frequently Asked Questions
    4. Validation Master Plan
    5. Risk Based Asssessment
    6. Complete Validation for a System (software development lifecycle)
    7. Automated Test Tools
    8. Infrastructure Requirements
    9. Change Control
    10. SOPs

     

    Who Should Attend:

     

    • VP of IT
    • Director of IT
    • Quality Managers
    • Project Managers (for DATA INTEGRITY / IT)
    • Validation Specialists
    • Database Administrators
    • System Administrators
    • Directors / Senior Directors of Discovery
    • Directors / Senior Directors of Development
    • Directors / Senior Directors of Commercialization
    • Document Managers
    • Training Managers
    • Consultants
    • Data Managers
    • Safety Managers

     

    Agenda:

     

    Day 1 Schedule

     

    Lecture 1:

    Introduction / Background

    • Introductions / Participants' Understanding
    • Participants' Objectives for the Course (Please come prepared to discuss)

    Lecture 2:

    Data Integrity

    • What is Data Integrity
    • How is it implemented
    • Data Integrity Frequently Asked Questions

    Lecture 3:

    21 CFR 11 & Annex 11

    • 21 CFR 11
    • Annex 11
    • 21 CFR 11.10(a) - Computer Systems Validation

    Lecture 4:

    Risk Assessment & Requirements

    • Risk Assessment for Requirements
    • Gathering Requirements
    • Entity Relationship Diagram
    • Process Decomposition
    • Exercise on how to create Requirements

     

    Day 2 Schedule

     

    Lecture 1:

    Design

    • Design Specifications
    • Software Configuration and Build
    • Exercise on how to create Design Specifications

    Lecture 2:

    Verification & Testing

    • Traceability Matrix
    • Verification and Testing
    • Other Documents

    Lecture 3:

    Special Topics

    • Test Tools for DATA INTEGRITY
    • Infrastructure Requirements

    Lecture 4:

    Change Control & SOPs

    • Change Control
    • SOPs

     

    Speaker

    Angela Bazigos

    CEO, Touchstone Technologies Silicon Valley

     

    Seasoned Executive with 40 years of experience in the Life Sciences & Healthcare Industries. Positions include Chief Compliance Officer http://morflearning.com/angelabazigos/. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Turnarounds and Business Development. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA http://www1.diahome.org/~/media/4FA562336EBD46C58CDC43A8B7773095.ashx Patent on speeding up software compliance https://www.google.com/patents/US8266578. Recently quoted in Wall Street Journal for using training to bring regulatory compliance to the Boardroom http://blogs.wsj.com/riskandcompliance/2015/07/24/using-training-to-bring-compliance-to-boardrooms/ National Trainer for Society of Quality Assurance. Comments / collaborates with FDA on new guidance documents. Former President of Pacific Regional Chapter of Society of Quality Assurance. Stanford's Who's Who for LifeSciences: http://www.stanfordwhoswho.com/Angela.Bazigos.7144112.html#overview.

     

    Location: SFO, CA Date:  December 7th & 8th, 2017 and Time: 9:00 AM to 6:00 PM

    Venue:  Hilton San Francisco Airport Bayfront   600 Airport Blvd, Burlingame, CA 94010, USA

     

     Price:

    Price: $1,495.00 (Seminar Fee for One Delegate)

    Register for 5 attendees   Price: $4,485.00 $7,475.00 You Save: $2,990.00 (40%)*

    Register for 10 attendees   Price: $8,222.00 $14,950.00 You Save: $6,728.00 (45%)*

    Register now and save $200. (Early Bird)

     

    Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar

    At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.

    As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.

    For More Information- https://www.globalcompliancepanel.com/control/sponsorship 

     

    Contact us today!

     

    NetZealous LLC DBA GlobalCompliancePanel

    john.robinson@globalcompliancepanel.com  

    support@globalcompliancepanel.com 

    Toll free: 1-800-447-9407

    Phone: 1-510-584-9661

     Website: http://www.globalcompliancepanel.com

     

    Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901052SEMINAR?globaleventslist.elsevier-December-2017-SEO

     

    Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/

    Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/

    Follow us on Twitter: https://twitter.com/GCPanel

     

     

    SFO, CA, United States
  • Dec 2017
    7
    Dec 2017
    8

    NetZealous DBA as GlobalCompliancePanel

    Course "Drug dissolution testing and establishing plasma drug levels in humans" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

    Overview:

    Drug dissolution testing is an essential and critical step for appropriate and efficient product development such as tablet and capsule. A number of approaches are used to conduct dissolution testing using different apparatuses and methods. Making a choice for an appropriate apparatus and method has always been confusing and challenging. This seminar will provide relevant pharmacokinetics and physiological background so that making this choice becomes easier and instinctive. No prior knowledge of pharmacokinetic and/or physiology is required; however, these will be explained in very simple terms to help attendees in selecting or developing a dissolution method. This seminar will describe in detail the theoretical aspect of the drug dissolution testing including method development. Pros and cons of different approaches will be explained in detail.

    Furthermore, drug dissolution testing is extensively conducted to provide an estimate/prediction of expected drug levels in humans. Commonly, concepts of convolution/deconvolution and in vitro-in vivo correlation (IVIVC) are described in this respect, unfortunately with limited success. Difficulties and limitations of the currently suggested approaches will be highlighted. This seminar will provide details of the underlying scientific principles involved in convolution, deconvolution and IVIVC techniques with simple practical examples. In this regard, a unique and simple approach based on convolution technique using spreadsheet software will be described.

     

    Why you should attend:

    Pharmaceutical product developments and assessments require extensive use of in vitro drug dissolution testing and convolution/deconvolution techniques for predicting plasma drug levels. Often such testing are presented in isolation (independent to their physiological link or relevance), however, this seminar will train attendees for developing these techniques using the principles of pharmacokinetics and physiology. The seminar will provide unique opportunity to learn scientifically valid drug dissolution testing and establishing plasma drug levels.

    It would be an unmatched opportunity to learn from an internationally recognized leader of the subject. A must attend seminar for anyone involved in product developments and assessments of solid oral dosage forms!

     

    Areas Covered in the Session:

     

    Physiological and Pharmacokinetic Principles:

    • Dissolution and related physiological terms: Drug absorption, permeation, relevant GI tract environment.
    • Basic and required pharmacokinetic principles including terminologies such as plasma drug concentration-time profiles/curves, rates of absorption and elimination, Cmax, Tmax, half-life, AUC, apparent volume of distribution, bioavailability/bioequivalence, etc.
    • Defining, and differentiating, drugs/medicines and drug/medicinal products
    • Defining quality of drugs/medicines and drug/medicinal products.
    • Generic vs innovator's products (Similarities and differences)

    Drug Dissolution Testing:

    • What is drug dissolution Testing and Why to conduct such tests?
    • Dissolution theory, sink conditions and intrinsic dissolution rate
    • Drug Dissolution Testing vs Solubility determination
    • Drug Dissolution vs Drug Release Testing - Is there a difference?
    • Dissolution Testing Apparatus:
      • Rotating basket (USP Apparatus 1)
      • Rotating paddle (USP Apparatus 2)
      • Reciprocating cylinder (USP Apparatus 3)
      • Flow-through cell (USP Apparatus 4)
      • Non-compendial (Crescent-shape)
    • Setting up a dissolution tester (e.g. Basket and paddle)
    • Dissolution equipment qualification (Performance Tablets vs Mechanical Calibration)
    • Tolerances and results Interpretation
      • Immediate release
      • Extended release
      • Delayed release
      • Current Requirements And Interpretations
    • Dissolution Method Developments
      • General requirements
      • Selection of dissolution medium
      • Apparatus and agitation rate
      • Sampling (time points & filtration)
      • Acceptance criteria (Pharmacopeial, similarity factor (F2), physiologically relevant, etc.)
      • QC method, bio/clinical relevant methods
      • Discriminatory vs non-discriminatory dissolution methods
      • Product dependent vs product independent Methods
      • Dissolution method validation vs analytical (quantitation) method validation
      • (Specificity, Linearity/range, Accuracy/recovery, Precision, Robustness)

    Linking Dissolution Results to Plasma Drug Levels:

    • Concepts of convolution, deconvolution and in vitro in vivo correlation (IVIVC), their requirements and (un)suitability for predicting plasma drug levels
    • Requirements for appropriate and relevant dissolution results
    • Convolution vs deconvolution methods which one to use and why?
    • Predicting plasma drug levels (Linking dissolution results to physiology)
    • Theoretical background
    • Converting dissolution results into plasma drug levels/profiles
    • Practical application with step-by-step instructions
    • Practical hands-on interactive demonstration of predicting/estimating of plasma drug levels using Excel spreadsheet software. Attendees may use their computers as well to follow the instructions for obtaining plasma drug levels.

     

    Who will benefit:

     

    Anyone working as bench chemist/analyst, supervisor, managers, director or vice president in pharmaceutical manufacturing facilities, including laboratories and associated contract organizations, of innovator and generic companies for human and animal products, in the following areas:

    • Pharmaceutical Development
    • Setting up analytical methods (pharmacopeial, regulatory or in-house developed)
    • R & D, both analytical and formulation
    • Project Management
    • Quality Control
    • Quality Assurance
    • Regulatory Affairs

     

    Agenda:

    Day 1 Schedule

     

    Lecture 1: (90 Mins)

    Physiological and Pharmacokinetic Principles

    Lecture 2: (60 Mins)

    [Continue] Physiological and Pharmacokinetic Principles
    (30 Mins) Question/Answer/discussion

    Lecture 3: (90 Mins)

    Drug Dissolution Testing

    Lecture 4: (60 Mins)

    [Continue] Drug Dissolution Testing 
    (30 Mins) Question/Answer/discussion

     

    Day 2 Schedule

     

    Lecture 1: (90 Mins)

    Linking Dissolution Results to Plasma Drug Levels

    Lecture 2: (60 Mins)

    [Continue] Linking Dissolution Results to Plasma Drug Levels
    (30 Mins) Question/Answer/discussion

    Lecture 3: (90 Mins)

    Practical hands-on interactive demonstration of predicting/estimating of plasma drug levels using Excel spreadsheet software

    Lecture 4: (60 Mins)

    [Continue] Practical hands-on interactive demonstration of predicting/estimating of plasma drug levels using Excel spreadsheet software 
    (30 Mins) Wrap-up 

     

    Speaker

    Dr. Saeed Qureshi

    Dr. Qureshi has extensive (30 years) working experience, as a research scientist, with a regulatory agency (Health Canada). He is an internationally known expert on the subject and maintains a full command in the areas of drug dissolution testing, pharmacokinetics, biopharmaceutics and analytical chemistry as related to animal and human studies for developing and evaluating pharmaceutical products. Specifically: (1) Quality assessment of pharmaceutical products based on pharmacokinetic studies (e.g. bioavailability/bioequivalence) in humans and animals, including validation of in vitro results with in vivo (bioavailability) studies. (2) In vitro drug release characterization of pharmaceutical products in particular oral and dermal using dissolution and/or diffusion (absorption/penetration through skin) techniques. (3) Analytical methods development/validation for drug disposition evaluation in humans and animals using chromatographic (e.g. HPLC, GC, TLC) and spectroscopic (e.g. UV, MS) techniques. (4) Data analysis using sophisticated (SAS) and general-purpose (e.g. MS Excel) software.

    Dr. Qureshi has extensively published in peer-reviewed journals and given numerous national and international presentations on the subject. Dr. Qureshi is very well known for his innovative but simple and practical ideas. Since 2010, he has been contributing and moderating a weblog (www.drug-dissolution-testing.com) which has become a popular source of new and thought provoking ideas for addressing the issues of product evaluations.

    Since 2015 Dr. Qureshi has been working as an independent consultant. A detailed description of his expertise and the services he provides may be obtained from the website (www.pharmacomechanics.com).

     

     Location: Boston, MA Date:  December 7th & 8th, 2017 and Time: 9:00 AM to 6:00 PM

    Venue:    Embassy Suites Boston Logan Airport   207 Porter St, Boston, MA 02128, USA

     

     Price:

    Price: $1,295.00 (Seminar Fee for One Delegate)

     Register for 5 attendees   Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*

    Register for 10 attendees   Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*

    Register now and save $200. (Early Bird)

    Until October 20, Early Bird Price: $1,295.00 From October 21 to December 05, Regular Price: $1,495.00

    Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar

    At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.

    As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.

    For More Information- https://www.globalcompliancepanel.com/control/sponsorship 

     

    Contact us today!

     

    NetZealous LLC DBA GlobalCompliancePanel

    john.robinson@globalcompliancepanel.com  

    support@globalcompliancepanel.com 

    Toll free: 1-800-447-9407

    Phone: 1-510-584-9661

     Website: http://www.globalcompliancepanel.com

     

    Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901306SEMINAR?globaleventslist.elsevier-December-2017-SEO

     

    Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/

    Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/

    Follow us on Twitter: https://twitter.com/GCPanel

     

    Boston, MA, United States
  • Dec 2017
    7
    Dec 2017
    10

    European Society of Medical Oncology

    Oncologists of today must adapt to rapid changes in practice. The promising results of immunotherapies in oncology are generating increasing interest from the oncology community and have the potential to become the standard of care.

    This year sees the launch of the ESMO Immuno Oncology Congress, the new highly-focused meeting devoted entirely to the development and use of immunotherapies against cancer.

    The creation of the ESMO Immuno Oncology Congress reflects ESMO’s commitment to providing oncologists who need to learn how to apply the latest standards of care in the immunotherapy of cancer with a comprehensive update in an environment rich with highly specialised professionals.

    Save the date for the ESMO Immuno Oncology Congress 2017.

    Le Grand-Saconnex, Geneva, Switzerland
  • Dec 2017
    7
    Dec 2017
    8

    NetZealous DBA as GlobalCompliancePanel

    Course "Applied Statistics, with Emphasis on Risk Management in R&D, QA/QC, and Manufacturing" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

     

    Overview:

     

    The 2-day seminar explains how to apply statistics to manage risks and verify/validate processes in R&D, QA/QC, and Manufacturing, with examples derived mainly from the medical device design/manufacturing industry. The flow of topics over the 2 days is as follows:

    • ISO standards and FDA/MDD regulations regarding the use of statistics.
    • Basic vocabulary and concepts, including distributions such as binomial, hypergeometric, and Normal, and transformations into Normality.
    • Statistical Process Control
    • Statistical methods for Design Verification
    • Statistical methods for Product/Process Qualification
    • Metrology: the statistical analysis of measurement uncertainty, and how it is used to establish QC specifications
    • How to craft "statistically valid conclusion statements" (e.g., for reports)
    • Summary recommendations

     

    Why you should attend:

     

    Almost all design and/or manufacturing companies evaluate product and processes either to manage risks, to validate processes, to establish product/process specifications, to QC to such specifications, and/or to monitor compliance to such specifications.

    The various statistical methods used to support such activities can be intimidating. If used incorrectly or inappropriately, statistical methods can result in new products being launched that should have been kept in R&D; or, conversely, new products not being launched that, if analyzed correctly, would have met all requirements. In QC, mistakenly chosen sample sizes and inappropriate statistical methods may result in purchased product being rejected that should have passed, and vice-versa.

    This seminar provides a practical approach to understanding how to interpret and use more than just a standard tool-box of statistical methods; topics include: Confidence intervals, t-tests, Normal K-tables, Normality tests, Confidence/reliability calculations, Reliability plotting (for extremely non-normal data), AQL sampling plans, Metrology (i.e., statistical analysis of measurement uncertainty ), and Statistical Process Control. Without a clear understanding and correct implementation of such methods, a company risks not only significantly increasing its complaint rates, scrap rates, and time-to-market, but also risks significantly reducing its product and service quality, its customer satisfaction levels, and its profit margins.

     

    Areas Covered in the Session:

     

    • FDA, ISO 9001/13485, and MDD requirements related to statistical methods
    • How to apply statistical methods to manage product-related risks to patient, doctor, and the designing/manufacturing company
    • Design Control processes (verification, validation, risk management, design input)
    • QA/QC processes (sampling plans, monitoring of validated processes, setting of QC specifications, evaluation of measurement equipment)
    • Manufacturing processes (process validation, equipment qualification)

     

    Who will benefit:

     

    • QA/QC Supervisor
    • Process Engineer
    • Manufacturing Engineer
    • QC/QC Technician
    • Manufacturing Technician
    • R&D Engineer

     

    Agenda:

    Day 1 Schedule

     

    Lecture 1:

    Regulatory Requirements

    Lecture 2:

    Vocabulary and Concepts

    Lecture 3:

    Confidence Intervals (attribute and variables data)

    Lecture 4:

    Normality Tests and Normality Transformations

    Lecture 5:

    Statistical Process Control (with focus on XbarR charts)

    Lecture 6:

    Confidence/Reliability calculations for Proportions

    Lecture 7:

    Confidence/Reliability calculations for Normally distributed data (K-tables)

    Lecture 8:

    Process Capability Indices calculations(Cp, Cpk, Pp, Ppk)

     

    Day 2 Schedule

     

    Lecture 1:

    Confidence/Reliability calculations using Reliability Plotting (e.g., for non-normal data and/or censored studies)

    Lecture 2:

    Confidence/Reliability calculations for MTTF and MTBF (this typically applies only to electronic equipment)

    Lecture 3:

    Statistical Significance: t-Tests and related "power" estimations

    Lecture 4:

    Metrology (Gage R&R, Correlation, Linearity, Bias , and Uncertainty Budgets)

    Lecture 5:

    QC Sampling Plans (C=0 and Z1.4 attribute AQL plans, and alternatives to such plans), including OC curves, AQL vs. LQL/LTPD, AOQL, and calculation of acceptance rates.

    Lecture 6:

    Statistically valid statements for use in reports

    Lecture 7:

    Summary and Implementation Recommendations

     

    Speaker

    John N. Zorich

    Statistical Consultant & Trainer, Ohlone College & SV Polytechnic 

     

    John N. Zorich, has spent 35 years in the medical device manufacturing industry; the first 20 years were as a "regular" employee in the areas of R&D, Manufacturing, QA/QC, and Regulatory; the last 15 years were as consultant in the areas of QA/QC and Statistics. His consulting clients in the area of statistics have included numerous start-ups as well as large corporations such as Boston Scientific, Novellus, and Siemens Medical. His experience as an instructor in statistics includes having given 3-day workshop/seminars for the past several years at Ohlone College (San Jose CA), 1-day training workshops in SPC for Silicon Valley Polytechnic Institute (San Jose CA) for several years, several 3-day courses for ASQ Biomedical, numerous seminars at ASQ meetings and conferences, and half-day seminars for numerous private clients. He creates and sells formally-validated statistical application spreadsheets that have been purchased by more than 75 companies, world-wide.

     

     Location: Houston, TX Date:  December 7th & 8th, 2017 and Time: 9:00 AM to 6:00 PM

    Venue: Doubletree by Hilton Houston Intercontinental Airport   15747 JFK Blvd Houston, TX 77032

     

     

     Price:

    Price: $1,295.00 (Seminar Fee for One Delegate)

     Register for 5 attendees   Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*

    Register for 10 attendees   Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*

    Register now and save $200. (Early Bird)

    Until October 20, Early Bird Price: $1,295.00 From October 21 to December 05, Regular Price: $1,495.00

    Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar

    At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.

    As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.

    For More Information- https://www.globalcompliancepanel.com/control/sponsorship 

     

    Contact us today!

     

    NetZealous LLC DBA GlobalCompliancePanel

    john.robinson@globalcompliancepanel.com  

    support@globalcompliancepanel.com 

    Toll free: 1-800-447-9407

    Phone: 1-510-584-9661

     Website: http://www.globalcompliancepanel.com

     

    Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901366SEMINAR?globaleventslist.elsevier-December-2017-SEO

     

    Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/

    Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/

    Follow us on Twitter: https://twitter.com/GCPanel

     

     

    Houston, TX, United States
  • Dec 2017
    8
    Dec 2017
    9

    Mayo Clinic Center for Individualized Medicine

    Pharmacogenomics (PGx), the study of how one’s genes may affect an individual’s response to medication, has reached the translational stage for various specialties in medicine.  This conference provides the background, resources and practical application examples to implement pharmacogenomics and make a difference in patients' lives. 

    Mayo Clinic experts, with experience leading the implementation of pharmacogenomics, will provide practical guidance on a range of topics, background and research involving pharmacogenomics, when to order testing, drug/gene selection, informatics, and case study working sessions.

    Phoenix, United States
  • Dec 2017
    13
    Dec 2017
    16

    American Academy of Anti-Aging Medicine

    Join us from December 13-16 for our upcoming 25th Annual World Congress in Las Vegas, marking a quarter of a century since A4M began its original mission: to deliver newly developed and groundbreaking technologies and techniques to audiences across the globe, with an array of impressive faculty members who assist our members in implementing and integrating new therapies into practice.

    Relax at the luxurious Venetian and Palazzo Resort, a five-diamond luxury hotel and casino resort located on the Las Vegas Strip. Enjoy the benefits of advanced CME education while partaking in some of the city's best nightlife, restaurants, shopping, and architecture. We hope you will join our team in un-tapping the potential of the sphere of healthcare, as we collectively and collaboratively redefine medicine.

    Conference Topics:

    Obesity / Weight Management

    Nutrition

    Gut-Brain-Heart Connection

    Genomics

    Chronic Infectious Diseases

    Sleep Disorders 

    Practice Management

    Men’s Health

    Aesthetic Medicine

    Integrative Cancer Therapies

    Precision / Personalized Medicine

    Las Vegas, United States
  • Dec 2017
    15

    Healthcare Conferences UK

    This conference focuses on Nurse Prescribing in Cancer Care. Through national updates and practical case studies the conference will demonstrate how the effective use of nurse prescribing in cancer care can improve patient care, experience and outcomes. The conference will focus on developing competence and confidence in nurse prescribing in cancer care, including using the new National Competency Framework for all Prescribers. Sessions will focus on chemotherapy prescribing, prescribing in a lung cancer, nurse prescribing for pain and symptom control, pharmacist prescribing within an oral anticancer medicine clinic, prescribing in end life care including controlled drugs, and nurse prescribing within follow up clinics and cancer survivorship services. The conference will also include a session on the development of radiographer led prescribing which has now been approved for advanced practice therapeutic radiographers.  A 20% discount is available by quoting ref: hcuk20ge when booking.

    London, United Kingdom
  • Dec 2017
    15

    Healthcare Conferences UK

    This conference focuses on Non Medical Prescribing in Cancer Care. Through national updates and practical case studies the conference will demonstrate how the effective use of non medical prescribing in cancer care can improve patient care, experience and outcomes.

    The conference will focus on developing competence and confidence in non medical prescribing in cancer care, including using the new National Competency Framework for all Prescribers. Sessions will focus on chemotherapy prescribing, prescribing in a lung cancer, non medical prescribing for pain and symptom control, pharmacist prescribing within an oral anticancer medicine clinic, prescribing in end life care including controlled drugs, and non medical prescribing within follow up clinics and cancer survivorship services. The conference will also include a session on the development of radiographer led prescribing which has now been approved for advanced practice therapeutic radiographers.  A 20% discount is available by quoting ref: hcuk20ge when booking.

     

    London, United Kingdom

Pages

Search this site

Search form

ECCO2017 symposium webcast: Treatment evolution in advanced GI malignancies

Welcome and introduction - Florian Lordick

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Featured Content

New Book Content


This online Resource Centre has been sponsored by Lilly Oncology

Note that Lilly Oncology has no editorial control over the content of this Resource Centre. The Resource Centre and all content therein has been subject to an independent editorial review.

Share